Detalles de la búsqueda
1.
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Breast Cancer;
2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735003
2.
Factors associated with non-completion of palliative radiotherapy for spinal metastasis in patients with terminal cancer: a retrospective study.
Ann Palliat Med;
13(2): 249-259, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584473
3.
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition.
Breast Cancer;
31(3): 347-357, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578563
4.
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Breast Cancer;
31(3): 340-346, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570435
5.
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.
Breast Cancer;
31(3): 335-339, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433181
6.
Augmented Reality-Assisted Transcanal Endoscopic Ear Surgery for Middle Ear Cholesteatoma.
J Clin Med;
13(6)2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38542003
7.
Impact of androgen deprivation therapy on cognitive function in men with prostate cancer.
BJUI Compass;
5(3): 356-358, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481674
8.
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition.
Breast Cancer;
31(1): 8-15, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934318
9.
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Breast Cancer Res Treat;
203(2): 225-234, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875670
10.
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition.
Breast Cancer;
31(1): 1-7, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843765
11.
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition.
Breast Cancer;
31(2): 166-178, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147174
12.
Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Cancers (Basel);
15(24)2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136326
13.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Breast Cancer;
30(6): 872-884, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804479
14.
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.
Clin Exp Med;
23(8): 5129-5138, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904008
15.
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
J Clin Oncol;
41(36): 5550-5560, 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801674
16.
Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06).
Cancer Med;
12(17): 17718-17730, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525895
17.
Correction: Yamamoto, Y.; Gerbi, S.A. Development of Transformation for Genome Editing of an Emerging Model Organism. Genes 2022, 13, 1108.
Genes (Basel);
14(7)2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37510416
18.
Time Analysis of Recidivism in Acquired Cholesteatoma Using the Kaplan-Meier Method.
Otol Neurotol;
44(6): e393-e397, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37254255
19.
Penetrating Trauma-Induced Perilymphatic Fistula: A Case Report and Literature Review.
Cureus;
15(3): e36106, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37065325
20.
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
Breast Cancer Res Treat;
199(2): 253-263, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000345